Clinical Research Directory
Browse clinical research sites, groups, and studies.
Influence of Body Composition on Chemotherapy Outcomes in Localized Breast Cancer
Sponsor: Centre Henri Becquerel
Summary
The purpose of this study is to determine if pharmacokinetics of docetaxel is modified by the body composition (assessed by the BMI but also by CT-scan) in patients treated by docetaxel as adjuvant treatment of a localized breast cancer
Official title: Influence of Body Composition, Total Body Fat and Body Mass Index on the Pharmacokinetics of Docetaxel in Localized Breast Cancer
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2023-10-25
Completion Date
2027-05-02
Last Updated
2026-01-02
Healthy Volunteers
No
Conditions
Interventions
pharmacokinetics blood sample assessment
pharmacokinetics blood sample assessment during the first exposure to docetaxel
Locations (1)
Centre Henri Becquerel
Rouen, France